Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein: A phase II clinical trial - Reply Journal Article
| Author: | Krug, L. M. |
| Article Title: | Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein: A phase II clinical trial - Reply |
| Keywords: | controlled study; protein expression; gene mutation; clinical trial; histopathology; cisplatin; antineoplastic agents; letter; imatinib; stem cell factor receptor; gene overexpression; proto-oncogene proteins c-kit; controlled clinical trial; phase 2 clinical trial; etoposide; lung neoplasms; pyrimidines; lung small cell cancer; autocrine effect; paracrine signaling; piperazines; carcinoma, small cell; growth stimulation |
| Journal Title: | Cancer |
| Volume: | 104 |
| Issue: | 9 |
| ISSN: | 0008-543X |
| Publisher: | Wiley Blackwell |
| Date Published: | 2005-11-01 |
| Start Page: | 2034 |
| Language: | English |
| DOI: | 10.1002/cncr.21407 |
| PUBMED: | 16161057 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 2" - "Export Date: 24 October 2012" - "CODEN: CANCA" - "Source: Scopus" |
